Special Offering :
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
The North America Electrocardiograph (ECG) Market would witness market growth of 5% CAGR during the forecast period (2018-2024). Electrocardiography (ECG) is a non-invasive medical test used in recording electrical activity of the heartbeat over a time span. Each heartbeat produces an electrical impulse, which is recorded with the help of electrodes. The electrodes detect smallest electrical changes in the skin which is caused due to heart muscle depolarizing during each heartbeat. Technological advancements of ECG devices such as their portability, handheld, novel electrodes & sensors, and smart phone integration would contribute to the market growth. Additionally, growing cases of cardiovascular diseases along with significantly growing older population further adds to the market growth. Moreover, emergence of novel ECG devices such as handheld ECG devices and ECG devices integrated with artificial intelligence systems would add to the growth of the market.
Based on Product, the market is segmented into Holter Monitors, Resting ECG, and Stress ECG. Holter Monitors segment is further bifurcated into Wired Holter Monitors and Wireless ECG Systems. On the basis of Lead Type, the market is segmented into Single Lead ECG, 3-6 Lead ECG, 12 Lead ECG. End Users covered under the report are Hospitals and Clinics, Home Settings & Ambulatory Surgical Centers (ASCs), and other end users. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America. The market research report covers the analysis of key stake holders of the market.
Key companies profiled in the report include Mindray Medical International Limited, Nihon Kohden Corporation, Medtronic Plc., Koninklijke Philips N.V (Philips Healthcare), General Electric (GE) (GE Healthcare), Schiller AG, Welch Allyn, CompuMed, Inc., Bionet, Opto Circuits Limited.